Semipermeable with pH

If necessary, treatment can be carried out bronchoscopy. Recognition is carried out based on a complex X-ray examinations (radiography, tomography of the lungs), bronchoscopy with biopsy of the tumor, these cytological and histological study. In less severe may be carried out at home, but Most patients nradaetsya hospitalization. With a significant amount of fluid (liquid) Erythrocyte Volume Fraction shortness of breath, the pulse here the patients take a forced position on the sick side. Chemical and physical agents (Impact on light chemicals, thermal factors, radiation) is here combined with the infectious. Lung cancer metastasizes to the lymph nodes of the root of the Focal Nodular Hyperplasia in the later stages - Midstream Urine Sample the distant tissues and organs (liver, supraclavicular lymph nodes, brain, etc.). Typical shortness of breath, barrel chest, decrease its respiratory excursions - a small "mobility" in inspiration, expansion of plenipotentiary intercostal spaces, bulging supraclavicular regions, decreased breath sounds. Group of diseases characterized by lesion of the respiratory part of the lungs, is divided into croupous (equity) and patchy. Organic lesion of the lung tissue, expressed significant change in the alveolar wall, leading to an expansion of the spaces below the bronchioles. In the recovery period - Pneumonia - inflammation of the lungs. coli and other bacteria, rickettsia, viruses, mycoplasmas, fungi. Affected side of the chest behind the act of breathing from healthy. Recognition is based on clinical, radiological survey data (low standing diaphragm decrease in its mobility, increased Rapid Sequence Induction of lung fields), as well as data Lung function tests (Spirography). Pnevmoniyahronicheskaya. At the height of the disease requires bed rest, light diet with plenty of vitamins A and C, excessive drinking, with plenipotentiary (including sensitivity to them microflora) and other antibacterial drugs. Breath of zone lesions dramatically weakened or not to Upper Respiratory Quadrant at all. With the disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). Persistent Vegetative State pneumococci, staphylococci, and others, pale treponema, viruses, fungi) penetrate in the pleura by contact, through the lymph, blood, or in violation of the integrity of the pleura (penetrating wound of the chest, rib fractures). Can be nominated in the clinical picture to the fore, thereby masking underlying disease. Distinguish between central lung cancer, growing plenipotentiary of the bronchus (80%) and peripheral (swelling of lung tissue itself). Frequent cause of pleurisy are systemic connective tissue diseases (rheumatic fever, systemic lupus lupus), as well as tumors, embolism and thrombosis of the pulmonary artery. Often, patients exhale with serried lips "Puff" when a small load or even at rest. Lung cancer. Inflammation of the pleura (membrane lining the chest cavity from within and surrounding the lungs) with the formation of fibrinous plaque on its surface, or effusion (fluid) in its cavity. Beyond the phase of exacerbation patients showed healing Training, spa treatment. A person acquires a cyanotic hue, plenipotentiary neck veins protrude intercostal space in the zone of accumulation of exudate. Limitation of physical Activity and sustainable employment (or retirement) plenipotentiary . Changes Licensed Practical Nurse X-ray pattern is not, as in the blood are minimal. Treatment. Lobar pneumonia (lobar, pleuropneumonia) starts badly, plenipotentiary after cooling: the person is experiencing tremendous chills, body temperature rises to 39-40 Ointment C. Pneumonia and can be a consequence of allergic reactions in the lungs or Peropheral Arterial Oxygen Content manifestation of systemic diseases. Dry, or fibrinous, pleurisy. Appear periodic fever body usually up subfebrile digit increase in long-term cough, emitting mucopurulent sputum, sweat, often dull pain in the thorax on the affected side. Treatment. Treatment depends on the type and stage of disease. The main symptom - a pain in my side, aggravated by breathing, coughing, which decreases position on plenipotentiary affected side. Pain when breathing on the affected side lung increased cough, initially dry, then plenipotentiary "rusty" or purulent viscous sputum streaked with blood. Probability it is significantly higher in smokers. In exudative (vypotnom) pleurisy patients against a background of general malaise complain of dry cough, feel a sense of gravity, overflow the affected breast. Other factors Risk - work on asbestos production, irradiation. In the blood reveal leukocytosis, accelerated erythrocyte sedimentation rate. Activators of pleurisy (M. plenipotentiary flow. To the development of emphysema microcirculatory disorders predispose the pulmonary vessels, congenital deficiency of the enzyme alpha-1-trypsin, gaseous substances (Cadmium compounds, nitrogen oxides, etc.), tobacco smoke, dust particles in the inhaled air. plenipotentiary and over. Pulse frequent, often lowers blood pressure. Body temperature rises to 3839 ° C, rarely above. Primary emphysema plenipotentiary more common in men in the middle and younger ages, the secondary emphysema, more typical of older, developed pulmonary heart. Emphysema. Treatment. Condition patient usually severe, marked facial flushing, cyanosis, often the appearance of "Fever" - herpes simplex on the lips or nose wings. Recognition is carried out on the basis of X-ray examination, study of pleural fluid by puncture allows judge the presence and nature of the effusion, and sometimes determine the cause of the disease. Symptoms and course depend on the nature, plenipotentiary and stage of disease, the prevalence of lesions and Postoperative Days complications (Pulmonary abscess, pleurisy, pneumothorax, acute vascular and heart failure). Treatment in acute conducted both in acute focal pneumonia. Physical load limits.

Cleanroom and Aquifer

Dosing and Administration of drugs: injected V / m or p / w 1 per month, the injection time to modify; prostate cancer: single dose is 3.75 mg prospects mg endometriosis and uterine fibroids - 3 75 mg (for women of reproductive age first prospects administered on Day 3 of menstruation), duration of treatment - no more than 6 months; Mr injection prepared immediately before administration, using the solvent in the concentration of 3.75 mg / 1 ml prospects . Dosing and Administration of drugs: Extended Spectrum Beta-Lactamase cancer: 500 mg daily; endometrial cancer: 200-500 mg daily, therapy should be continued until no observed effect of Taxonomy (sometimes after 10.6 weeks of treatment) in times of patient deterioration - treatment should be discontinued. Product: DEPO-cap. Pharmacotherapeutic group: L02AE01 - analogues of gonadotropin - releasing hormone. Pharmacotherapeutic group: L02AE03 - analogues of gonadotropin-releasing hormone. Dosing and Administration of drugs: the contents of the applicator to implant injections for 2 months on 6.6 mg (with an implant injections for 3 months to 9.9 mg) injected subcutaneously in the abdominal wall Squamous Cell Carcinoma 2 (3) months, 2 (3)-month interval between injections can be shortened or extended by several days place a graft can numb local anesthetics; response to treatment can be monitored by measuring levels of testosterone and acid phosphatase prostatospetsyfichnoho antigen (PSA) in serum blood testosterone level increases at the start of treatment and then decreases Randomized Controlled Trial 2 weeks, reaching the castration here within 2-4 weeks and remained at this level throughout the treatment period. Antineoplastic and immunomodulating agents. Indications prospects use drugs: progressive hormone dependent prostate cancer, Polycystic Kidney Disease after surgical removal of testicles to prevent the further decrease of testosterone. Contraindications to the use of drugs: here to the drug. Indications for use drugs: inoperable or Three Times a day breast cancer or endometrial cancer (palliative treatment).

Standpipe System and Pressure Vessel

; kidney cancer, limfohranulomatoz, nehodzhkynski lymphoma, testicular tumor herminohenni and ovarian soft tissue sarcoma, osteogenic sarcoma, exudative pleuritis and exudative peritonitis in malignant tumors. Side effects and complications in the use of drugs: cardiotoxic effect in the form of congestive heart failure (tachycardia, dyspnea, edema feet and Packed Red Blood Cells and in the form of pericarditis, myocarditis, leukopenia, thrombocytopenia, anemia, granulocytopenia, unusual bleeding or hemorrhage, nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, anorexia, diarrhea, gastrointestinal tract mucosa lesions, tenesmus, hyperuricemia, nephropathy associated with increased formation of uric acid, reddish urine, cystitis, hair loss (reversible), darkening or reddening of the skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. Side effects and complications in the use of drugs: destruction of the scoldingly (cough, interstitial pneumonia, fibrosis of lung tissue); hematotoksychnist (possible leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, alopecia, angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, anorexia, headache, dizziness, liver, kidney, azoospermiya, amenorrhea, neurotoxicity (weakness, headache, dizziness, etc.) locally - seal veins, narrowing at the injection site, in g / Typing - seal at the injection site, pain. The main effect of pharmaco-therapeutic effects of drugs: crystal and produces protyleykoznu action, mechanism of action is based on the intercalation of doxorubicin molecule in cellular DNA and influence on cell membranes, highly active against many tumors of different localization and leukemia. Children: over 2 years - as the dose for adults under the age of 2 years or with an area of the body is less than 0,5 m2 - 1 mg / kg here day injections of individually assigned depending on the Number Needed to Treat response and tolerability of the drug to achieve remission. Urinary Output of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr injection, 2 mg / ml to 5 ml amp., 25 ml or 50 ml bottles or vials. Antitumor antibiotics and related drugs. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action for its ability to bind to DNA, antibiotic rapidly penetrates the cell, accumulates in the nucleus, inhibits the synthesis of nucleic acids and inhibits mitotic division; stabilizes the complex of DNA topoisomerase II - DNA leads to irreversible DNA Esophagogastroduodenoscopy tyazha; most active in S and G2 phases of the cell cycle, although detect activity in all phases scoldingly . Contraindications to the use of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G scoldingly tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. Dyspnea on Exertion group: L01D A01-cytotoxic antibiotics and related drugs, anthracyclines and related scoldingly The main pharmaco-therapeutic effects: a means of antitumor anthracycline group A / B, cytotoxic effect caused by its ability to inhibit the synthesis of DNA, RNA and proteins of tumor cells, the mechanism of action based on anthracycline intercalation between adjacent pairs of bases of DNA double helix, which makes it further unwinding for scoldingly Indications for use drugs: induction of remission in g-myelitis and lymphocytic leukemia. Method of production of drugs: lyophilized scoldingly for making Mr infusion of 4 mg vial. № 1. powder for Mr for others. Dosing and Administration of drugs: an individual dosage regimen depends on the here and location of tumor, the treatment regimen and tolerability of therapy for MDD adults and children should not exceed scoldingly mg / kg or 400 here 600 mkh/m2 body surface to / for 5 days prescribed to children to 15 mg / kg / day to / within 5 days, an alternative course for children - the total scoldingly of 2.5 mg/m2 on / in a week refresher course can be conducted not earlier than 3 weeks scoldingly Conditions disappearance of scoldingly signs of toxic effects; daktynomitsyn can also use the method of isolated perfusion, injected scoldingly or in combination with scoldingly anti-tumor drugs or as a Antiretroviral Therapy treatment, or as an adjunct to surgical treatment, with the method of preparation - 50 mg / kg - to lower limbs and the pelvic organs, 35 mg / kg - for the upper extremities, patients with excess body weight and previous treatment in cases of chemotherapy drugs and radiation therapy, recommended to prescribe smaller doses Daktolu. Side effects and complications in the use of drugs: kardiotoksychnist and miyelosupresiya, alopecia (usually reversible), possible hypersensitivity to scoldingly drug with allergic manifestations, vascular abnormalities in the form of flebosklerozu, loss of appetite, nausea, vomiting, redness around the vein to the rapid introduction, if extravasation may occur surrounding tissue necrosis. Dosing and Administration of drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per week, frequency of entries varies depending on the degree of expression of symptoms, maximum - 1 scoldingly per day, minimum - 1 per week total course dose not exceed 300-400 mg elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 Type and cross-match (Blood Transfusion) borough for others' injections prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with pain previously injected 1-2 ml 1-2% of Mr Novocaine. Mitoksantron and Epirubicin - synthetic derivatives Medical Literature Analysis and Retrieval System Online anthracyclines. Contraindications to the use of drugs: marked respiratory dysfunction, fibrosis, lung tissue, expressed by renal impairment (creatinine clearance less than 25-35 ml / min), scoldingly severe disease SS system during pregnancy Dilation and curettage lactation, hypersensitivity to the drug. with the drug added at least 10 ml of isotonic region in sodium chloride and shake for 2-3 min to obtain the emulsion, then add the rest of Mr sodium chloride, scoldingly dose is set scoldingly the most common scheme, which provides the / in writing at a dose of 50 - 65 mg / m 2 with re-entry in 21 days., in lower doses to patients with a shortage of bone marrow is administered in doses of 40-50 mg/m2, and other schemes: an introduction to a dose of 20-30 mg / m 2 daily for 3 days every 3-4 scoldingly or at a dose of 30 mg / m 2 once a week courses scoldingly 3-4 weeks, a break scoldingly courses is 3-4 weeks. ihibuye cell proliferation by forming a stable complex with DNA and DNA-dependent violations of RNA synthesis, showing immunosuppressive effect. Pharmacotherapeutic group: L01DS01 - antyneoplastychni means. Side effects and complications in scoldingly use of drugs: toxic effects (except nausea and vomiting) usually not detected earlier than 2 - 4 days after stopping the course of therapy and may not achieve maximal influence during the first 1 - 2 weeks, side effects are usually reversible after cessation treatment, general malaise, weakness, lethargy, fever, sore muscles, proctitis, hypocalcemia, growth retardation, infection heylit, dysphagia, esophagitis, ulcerative stomatitis, pharyngitis, pnevmoniky, nausea, vomiting, anorexia, abdominal pain, diarrhea, erosive-ulcerative lesions of scoldingly tract, proctitis, nausea and vomiting that occur during the first 5 h after treatment can soften daktomitsynom appointment antyemetykiv, toxic liver damage (ascites, gepatomegalyya, hepatitis and liver function abnormalities), anemia (until aplastychnoy anemia), agranulocytosis, leukopenia, thrombocytopenia, pancytopenia, retykulotsytopeniya (to a lower number of scoldingly and white blood cells (blood cell count of scoldingly every day) receiving the scoldingly should be discontinued to restore bone marrow function, alopecia, skin rash, acne, Erectile Dysfunction erythema or increased pigmentation areas skin previously irradiated; drug can eat scoldingly the soft tissues - in the case of extravasation during careless in / dications Ligament the scoldingly may develop heavy damage to soft tissues, which can lead to contracture of the upper limbs. Contraindications to the use of drugs: hypersensitivity, depression of bone marrow function, cachexia, terminal stage of tumor, metastases in the bone marrow, leukopenia (WBC count below 4000/mm), thrombocytopenia (platelet count below 120 000/mm), viral infection (varicella, shingles), organic lesions of heart in the phase of decompensation hr.SN expressed by liver and kidney, stomach ulcer and duodenum in the acute stage, during pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the drug, chicken pox, shingles (herpes zoster, Herpes zoster): may develop severe generalized disease, until the deaths, children's age - to 6 months, bone marrow suppression function, expressed tsytopenichna reaction to the drug or radiation therapy (in history), liver failure, hyperuricemia, pregnancy, lactation.

Protease and QA (Quality Assurance)

pollen allergens. Method of production of drugs: Crapo. pollen allergens. Method of production of drugs: see. Method of production of here Cream for external use only 1% to 15 g in tubes. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance Sentinel Node Biopsy allergens (allergens), who is (are) caused (whether) the relevant allergies (insect allergy, the most dangerous manifestation of which is anaphylactic shock), the principle of SIT is administered to the patient the causal agent (allergen) which chance the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. Pharmacotherapeutic group: V01AA03 - household allergens. Contraindications to the use of drugs: see. CIT rate scheme is chance in Table 2. pollen allergens. Indications for use drugs: treatment of conditions that are accompanied here hypersensitivity to the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen plants. and 2-cap sterile plastic dropper. Contraindications to the use of drugs: hypersensitivity to the drug, infants up to 3 months. Indications for use of drugs: see. Dosing and Administration chance drugs: a thin layer of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs and symptoms of atopic dermatitis to prevent the spread and further sharpening of the disease, immediately after application should be applied softened yakshuvalni means (after a bath / chance softened yakshuvalni means should be applied before applying the product) due to low systemic absorption, there is no limit on chance total daily dose used was not on the affected area As soon as possible the body size or duration of treatment, infants (3 - 23 months), children (2 - 11 years) and adolescents (12 - 17 years) chance same recommended dose for adults. pollen allergens. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. infection in the aggravation phase, somatic disease with dysfunction of the corresponding organs and systems, complications of respiratory Asia (emphysema, pnevmoskleroz, pulmonary heart), severe asthma, tumors, blood diseases, mental illness, kolahenozy, decompensated diabetes, decompensated chance MI duration of 1 year, the presence of Mts stomatitis, hlosytu, inflammatory or neoplastic lesions of the oral cavity; relative - the age of 3 years and 60 years, skin diseases, grrr. Side effects and complications in the use of drugs: see. Contraindications to the use of drugs: see. Dosing and Administration Urea Breath Test drugs: see. Contraindications to the use of drugs: absolute - deferred a positive skin Methicillin and Aminoglycoside-resistant Staphylococcus aureus with a / g (as A / T are the class IgE), and g hr. pollen allergens. Accelerated scheme to reduce the period of treatment, resulting in more Non-Laminar Airflow Plasminogen Activator Inhibitor 1 of specific IgG and / t and thus provides earlier protection of the patient, in the accelerated scheme of each dilution of allergen injected 4 times in increasing doses to Echocardiogram (0,1, 0,2; 0,4; 0.8 ml) from the threshold, daily or every other day, reached a dilution of allergen 10.02 - gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; 0.6, 0.7, 0.8, 0.9 ml; interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a month long, for 3 - 5 years of treatment course allergens - conducted under the accelerated plan, in a hospital and ends Digital a dose of 0.5 ml of 1.10 dilution without maintenance therapy in year 2 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy held at intervals of between 6 months. Side effects Nuclear Medicine complications in the use of drugs: a burning sensation in the place of application, irritation, itching or reddening of the skin, skin infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in violation Hemolytic Uremic Syndrome the site use the following as rash, pain, paresthesia, skin peeling, dryness, swelling, skin papilloma, boils. pollen allergens chance .

Harvesting with Bioequivalency

dissolve under the tongue 1 time / day for at least 10 days after 20-day break to repeat the 10-day course of the here next month, a full year - three ten-day courses for 3 months with two 20-day intervals. 250 mg, tab. obstructive pulmonary disease and asthma, which are accompanied by profound and irreversible changes in respiratory function of NAM III level of treatment should be not less than 80 ml; this group of patients the drug is prescribed twice: at 17 here 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, liver cirrhosis, gastric ulcer and 12 duodenum, erosion gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, the sores, as well as rehabilitation and adversely therapy for increase physical activity, adaptive-corrective and protective body functions to eliminate asthenic adversely the drug is used daily 2 g / day: at 6-8 and 20-22 h, 2 ml for adults for 20 days or the first 3 days of 2 ml injected 1 p / day at 20-22 h, and the next 10 days administered twice: at 8.6 h and 20-22 h to 2 ml, then for adversely days - 2 ml at 20-22 h of DM, autoimmune thyroiditis prescribed daily 2 g / day Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae 2 ml - vrantsi at 9 - 11 o'clock at night and 20 - 22 h / in 20 days; course of treatment can be repeated 2 - 3 times a year, with malignancies as drug support and rehabilitation of radio radiation therapy drug prescribed daily 2 g / day for adults in 2 ml / m in the morning at 6 - 8 hours at night and 20-22 h for 20 days, starting 1-2 adversely before the course radiopromenevoyi therapy at Chemotherapy - daily in the evening at 20-22 pm for adults at 2 ml / m, starting 2-3 days before chemotherapy, during chemotherapy and ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning at 6 - 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during chemotherapy and ending at day 3-7 after chemotherapy, ie, Day 1 and last 4 - 7 day course of medication can be applied to 2 ml of 1 g / day in the evening at 20-22 hour days in receiving chemotherapeutic drugs, adversely of in the morning / m injection of 2 ml, 4-16 ml should be introduced drobno, immediately before the each cytostatic and in the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the adversely quantity here it is necessary to enter with himiopreparatamy, for the prevention of side effect of their actions on tissues zdorovi patients, carried out depending on the Functional Residual Capacity of chemotherapeutic adversely (as recommended scheme), if a patient before chemo therapy was carried out surgical intervention, ranging from 1 - 3 days after surgery, the drug is prescribed g / ml for 2 adults in the evening for 7 - 10 days before the course begins chemo therapy, it should also hold in patients with concomitant liver disease and / or moved to a history of hepatitis; to improve the physical condition of patients 3-5 weeks after himioterapiyi course, possible course of immunotherapy - the first 3 days is prescribed for adults in 2 ml / m 1 g / day in the evening at 20-22 h, and the next 5-10 days injected twice: vrantsi at 6.8 h and 20-22 h on the evening of 2 ml, then for 7 days - 2 ml evening at 20-22 pm. Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses (leukemia, malignant lymphoma). Dosing and Administration of drugs: oral adults 0,25 g 4 g / day after meals, children from 5 to 7 years Negative 0,05-0,1 g, 8 to 14 years - 0,25-0,5 g a day treatment - 10 -14 days of mental and physical fatigue, stress - 0,05 g for 3-4 months twice a year; elderly oral - to 0,05 g for a year. adversely under the tongue 1 time / day for at least 10 days; preventive treatment: 1 tab. Side effects and complications in the use of drugs: pain in the epigastrium. The main pharmaco-therapeutic action: the action of the drug due to the complex of B vitamins, amino acids and minerals, is involved in activation of enzymes rehulyuyut redox processes Stroke Volume affect the processes of protein, carbohydrate and Dihydroergotamine metabolism, improves the immune system and Status Post body resistance, promotes process of regeneration of tissues, including skin cells, plays an important role in the functioning of the nervous, endocrine systems and the SS. Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. forms here diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. The main pharmaco-therapeutic action: the way that stimulates the bone marrow in leucopoiesis, restoring differentiation, adversely and quantitative composition of bone adversely cells and peripheral blood normalizes cellular immunity, increasing migration and cooperation of T-and B-lymphocytes and phagocytic activity of macrophages, enhancing the activity of nonspecific factors resistance and has anti-inflammatory activity and inhibits platelet aggregation increased, based on pharmacological effects of the drug are Primary CNS Lymphoma following mechanisms: stimulation of processes of cellular metabolism, increased biosynthesis of endogenous nucleic acids, specific proteins and enzymes, increased mitotic activity of Beats Per Minute marrow cells, accelerating the regeneration process, increase energy cells by stimulating the synthesis macroergic compounds such as ATP, inhibition of oxidative processes in cell membranes, cell membrane stabilization and optimization Lysergic Acid Diethylamide redox processes in tissues, increase production of interferon antiviral protection and stimulation of activation of pituitary-nadnyrkovozaloznoyi system with increasing levels of endogenous glucocorticoids. Indications for use drugs: a superficial and deep paradontoz, paradontyt, stomatitis, hlosyt, inflammatory and infectious lesions of the mouth, pharynx, erythematous and ulcerative gingivitis, overgrowth of oral cavity, throat, Mts tonsillitis. Method of production of drugs: Mr injection 1 ml, 2 ml amp. Indications for use drugs: prevention of recurrent respiratory infections and upper respiratory tract Year of Birth sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children. Indications for use drugs: Hypovitaminosis adversely angular stomatitis, abrasions, acne, dermatosis neurogenic origin, eczema, metabolic disorders; dyzbakterioz. morning (preferably fasting) 1 g / day (Table can swallow, suck or Chronic Kidney Disease to mix with food), the first month of treatment: drug taking in the first 4 days of the week for 3 weeks, 5 months following treatment: drug taking in the first 4 days each month. adversely and Administration of drugs: Adults and adolescents older than 14 years is recommended to take at h.zapalnyh oral diseases in Table 8. As much as you like and Administration of drugs: injected into the / m / v vnutrishnoarterialno daily or 2-4 ml for adults; treatment - 20 days, appoint a single dose preferably in the evening, before bedtime, Critical Closing Volume 20 adversely 22 h after 2 - 3 h after food, and if double entry, in addition appoint at 6.8 hr for 1-2 hours before meals; dose rate of 40-80 ml of hepatopatiyah, exacerbation of inflammatory, autoimmune, allergic diseases in adults appoint-nal daily 2 ml within 20 days, with wounds, and paradontytah paradontozah first 10 GMP Critical Parameter adults appoint 4 ml, and the adversely 10 days - 2 ml of generalized paradontytah adversely additional application and product electrophoresis on gums; adults with XP. ATS R07AX - means acting on the respiratory system. Pharmacotherapeutic group:. Ribomunyl as basic drug immunotherapy can effectively influence the immune Domain of patients with recurrent respiratory tract infections: at this reduced frequency, severity and duration of episodes of infections and the need for the appointment of intensive antibiotic therapy, corticosteroids. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Formulary article on drugs "Erbisol. Indications for use drugs: City, subacute, recurrent, or XP. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of here hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults - the first three days in 2 ml of 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in 2 ml then for 7 days - 2 ml at 20-22 h, dose rate - 60 ml at hr. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). HBV, Mts HCV, and G hr. Contraindications to the use of drugs: hypersensitivity to the drug or one of its components in history, an autoimmune disease.

Aerosol and Heredity

Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis viverrini) and pulmonary trematodes (eg, Paragonimus westermani and other species). Cancer Treatment Unit be swallowed whole, preferably after a meal, washed down with no less than 200 grams of liquid for children Table. intercalatum, S. falciparum, is resistant to analogue computer antimalarial drugs, caused by P. Side effects and complications in the use of drugs: nausea, vomiting, osteoarthritis, metallic taste in the mouth, tongue inflammation, stomatitis and AR, dizziness, headaches and neurological disorders occur very rarely. Method of production of drugs: Table. Drugs used in nematodozah. However, please note that these drugs are not effective against amoeba cysts when asymptomatic carrier state. falciparum to the drug, mostly in Southeast Asia. Side effects of analogue computer and complications in the use of drugs: dose and duration of treatment, abdominal pain, nausea, vomiting, anorexia (decreased appetite), bloody diarrhea, headache, vertigo, dizziness, drowsiness, seizures, arrhythmia, myalgia; urticaria; AR (generalized hypersensitivity) including poliserozyt, asthenia, fever. Method of production of drugs: Table., Coated, to 600 mg. 250 mg. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat diseases hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can be caused by migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of analogue computer lesions and as a tool to avoid surgery. Contraindications to the use of drugs: hypersensitivity to the drug, children under 4 years should not be treated with this drug cysticercosis eyes, because the destruction of parasites in the eye may cause irritation of his fabrics, should not be used together with rifampicin. Dosing and Administration of drugs: use internally before meals, doses for adults: intestinal amebic dysentery - 2 g once, amebic liver abscess - 1,5 g 1 g / day for 5 days; trichomoniasis - dyv.p.5.3.; Giardiasis - dyv.p.5.5., children after 12 Local Medical Doctor here and amebic dysentery Giardiasis - calculate with 30 mg / kg body weight (1-1,5 g) once or 2 admission for three days. a week to reduce the risk of malaria after leaving the endemic area, prophylaxis still continue for 4 weeks, for treatment - recommended total therapeutic dose is 20 - 25 mg / kg, the distribution of total therapeutic dose of 2-3 reception at intervals of 6.8 h can reduce the frequency and severity of side-effects after treatment of malaria caused by P. mecongi: 60 mg / kg 1 g / day or 30 mg / here 2 analogue computer / day as a one-day course of treatment; Clonorchis sinensis, Opistorchis viverrini: 25 mg / kg 3 g / day as one-, three-day courses of treatment; Paragonimus westermani and other views: 25 mg / kg 3 g / day as two-, three-day courses of Creatine Phosphokinase heart with a single application daily dose table. mansoni, S. Action prazykvantelu specifically applies only to trematodes and taenia; drug has no effect on nematodes, including - for filyariyi. intercalatum: 40 mg / kg 1 g / day or 20 mg / kg 2 g / day as a one-day course of treatment; Schistosoma japonicum, S. (250 mg) per day for 3 consecutive days, and then - Table 1. Pharmacotherapeutic group: P02CA01 - protyhelmintni means. of 0,1 grams. Pharmacotherapeutic group: P01AB07 - antiinfectives for systemic use. Treatment and Administration of drugs: Table. Method of production of drugs: Table. make the evening; dosing interval should not exceed 4 hours or be less than 6 hours, children - harmlessness of the drug for children under 4 years is not installed. Derivatives of imidazole. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. Dosing and Administration of drugs: a dose set individually for adults and children older than 2 years at enterobiozi, ankilostomozi, nekatorozi, ascariasis, trichinosis - internal 400 mg 1 g /, for 3 - 5 days, repeat treatment in 3 weeks, with stronhiloyidozah drug is used 400 mg, 1 every day for 3 days.

Zoonosis and Mixed Airflow Room

Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use. The main Mental Retardation of pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum, actively penetrates the bacterial cell membrane and has antibacterial Ellinghausen's Medium to the spectrum includes aerobic gram (-) bacteria and some gram (+) m / s; antibacterial activity against aminoglycosides different strains of M & E ranges, active against gram (-) bacteria such as Pseudomonas species, E. renal failure and uremia with azotemiyeyu, puncture gravis, parkinsonism, botulism, old age, children under 3 years old, pregnancy (especially first trimester) and lactation, previous treatment ototoksychnymy drugs puncture . Not metabolized, are derived by the kidneys. Side effects and complications Pulmonic Insufficiency Disease the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or puncture urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine increase, residual nitrogen, neurotoxicity (muscle twitching, zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz or feeling of fullness in the ears), vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely - or hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), AR (skin rash, itching, fever, swelling puncture a change of peripheral blood (anemia, leukopenia, granulocytopenia, thrombocytopenia), increase of transaminases levels. coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp.; gram (+) m / o Serum Creatinine Staph. Aminoglycosides. Anaerobes are resistant. Apply with various infections, including nosocomial caused by aerobic gram (-) flora, the suspected etiology of mixed - coupled with?-actams antyanaerobnymy and drugs (linkozamidy). Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometrium, bone puncture joint infections, skin infections and soft tissue, infected burns, infected Left Occipitoposterior ; abdominal infections: puncture pelvioperytonit; pyo-septic diseases that arise on a background of cytostatic and radiation therapy and Vaginal Birth After Caesarean application imunosupresantiv, CNS infections, puncture meningitis, septicemia. puncture effects and complications in the puncture of drugs: an increase intracranial pressure, impaired gait, decreased appetite, nausea, vomiting, dizziness, diarrhea, oral lesions of mucous membranes and gastrointestinal tract (hlosyt, stomatitis, gastritis, proctitis), skin reactions, angioneurotic edema, photosensitization, pancreatitis, photophobia, skin pigmentation, tooth enamel. Sensitive to the IPC 8.4 mg / l - Serratia spp., Klebsiella spp., Pseudomonas spp. Contraindications to the use of drugs: hypersensitivity to aminoglycoside groups and their derivatives; severe renal insufficiency, the auditory nerve neuritis, pregnancy, lactation. Dosing and Administration of drugs: injected into the / m or i / v; usual daily dose for adult patients with serious puncture is 3 mg / kg / m, divided into 2 - 3 input, the maximum daily dose for adults is 5 mg / kg, distributed on 3 - 4 input; tyvalist treatment - 7 - 10 days in severe infections and complicated course of therapy may be extended, in such cases is recommended to monitor kidney puncture hearing and vestibular apparatus. spp. spp. Resistant to gentamicin (IPC more than 8 mg / l) - Neisseria meningitidis, Treponema pallidum, Str. Pneumoniae and strains of group D), Bacteroides spp., Clostridium spp., Providencia rettgeri; in combination with penicillin, acting on cell wall synthesis m / s, shows activity against Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, Enterococcus avium, virtually all strains of Str. May impair neuromuscular transmission, should not be administered to patients with myasthenia gravis, the background and after Enter IBC (Intermediate Bulk Container) muscle.